Research Article
Development and Validation of Spectrophotometric Methods for Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form
Table 5
Summary of validation parameters.
| Methods | Method 1 | Method 2 | VAL | HCT | VAL | HCT |
| | 249.4 nm | 272.6 nm | 258.4 nm | 272.6 nm | Linearity range (g/mL) | 12.8–76.8 | 2–12 | 12.8–76.8 | 2–12 | Regression equation | | | | | Slope (m) | 0.150 | 0.181 | 0.0269 | 0.0542 | – intercept () | 0.081 | 0.079 | 0.064 | 0.013 | Correlation coefficient () | 0.998 | 0.998 | 0.999 | 0.999 | % recovery () | 100.20 | 100.19 | 100.40 | 100.20 | LOD (g/mL) | 1.60 | 0.37 | 1.60 | 0.32 | LOQ (g/mL) | 4.87 | 1.12 | 4.86 | 0.97 | Molar absorptivity (lit/mole/cm) | 14894.78 | 16613.89 | 12242.19 | 16643.66 | Sandell’s sensitivity (g/sqcm/0.001) | 0.02924 | 0.01793 | 0.03558 | 0.01789 | Standard error | | | | | Precision (% RSD) | | | | | Intra- day () | 0.334 | 1.361 | 1.143 | 1.044 | Inter-day () | 0.931 | 1.402 | 0.920 | 1.210 | Specificity (% RSD) | | | | | Addition of MCC | 1.6 | 1.8 | 0.9 | 1.2 | Addition of starch | 0.5 | 0.8 | 0.3 | 0.7 | Ruggedness (% RSD) | | | | | Analyst I () | 0.5 | 0.6 | 0.2 | 0.5 | Analyst II () | 1.2 | 1.1 | 1.1 | 0.9 | Robustness (% RSD) | | | | | 0.2 N NaOH () | 0.8 | 1.2 | 1.6 | 1.5 | 0.5 N NaOH () | 0.5 | 1.3 | 0.8 | 1.2 |
|
|